RxDoctor Payments Data

Alissa Watson, APRN

Nurse Practitioner · Glastonbury, CTNPI 1174032155

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.7% of the total across 391 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 27.2% of the total. 2025 is the largest year on record at $3,083, 3.4 times the $906 reported in 2021. Among nurse practitioner clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,365in general payments, 2019–2025

Across 391 payments — averaging $23.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Johnson & Johnson$1K
  • E.r. Squibb & Sons, L.L.C.$806
  • Regeneron Healthcare Solutions, Inc.$540
  • UCB, Inc.$488
  • Amgen$452
  • plus $3K from 20 others

What the payments were for

  • Food & beverage$8,86895%
  • Education$4975%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,365 in reported general payments places this provider in the 95th percentile of 1,162 nurse practitioner providers in Connecticut.

See all nurse practitioner providers in Connecticut

Medicare billing

Part B allowed, 2024
$33,015
Medicare patients
232
Services billed
467

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab21$77,470
Metronidazole26$1,850
Clobetasol Propionate39$1,046
Ketoconazole112$1,010
Doxycycline Monohydrate12$984
Doxycycline Hyclate14$808
Triamcinolone Acetonide52$569
Betamethasone Dipropionate13$399
ValacyclovirValacyclovir Hcl26$237
CiclopiroxCiclopirox Olamine12$214
Minoxidil12$181
Ammonium Lactate15$144
Mupirocin25$137
Hydrocortisone21$63

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Glastonbury

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →